Advertisement
Canada markets close in 5 hours 10 minutes

  • S&P/TSX

    21,743.84
    +87.79 (+0.41%)
     

  • S&P 500

    5,047.24
    +25.03 (+0.50%)
     

  • DOW

    38,022.69
    +269.38 (+0.71%)
     

  • CAD/USD

    0.7271
    +0.0008 (+0.10%)
     

  • CRUDE OIL

    82.52
    -0.17 (-0.21%)
     

  • Bitcoin CAD

    87,805.55
    +2,733.59 (+3.21%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • GOLD FUTURES

    2,387.00
    -1.40 (-0.06%)
     

  • RUSSELL 2000

    1,962.00
    +14.05 (+0.72%)
     

  • 10-Yr Bond

    4.6270
    +0.0420 (+0.92%)
     

  • NASDAQ

    15,748.60
    +65.23 (+0.42%)
     

  • VOLATILITY

    17.64
    -0.57 (-3.13%)
     

  • FTSE

    7,876.70
    +28.71 (+0.37%)
     

  • NIKKEI 225

    38,079.70
    +117.90 (+0.31%)
     

  • CAD/EUR

    0.6818
    +0.0016 (+0.24%)
     
MARKETS LIVE BLOG:

STOCKS RISE AS TECHS REVIVE, WITH NETFLIX EARNINGS ON TAP

Tesla shares slide to 52-week low; stock is down roughly 40% year-to-date

Pluristem Therapeutics Inc. (PSTI) Catches Eye: Stock Jumps 5.1%

Zacks Equity Research
Updated

Pluristem Therapeutics Inc. PSTI  was a big mover last session, as the company saw its shares rise over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $1.23–$1.56 in the past one-month time frame, witnessed a sharp increase on Friday.

The company has seen no estimate revisions over the past one month, while the Zacks Consensus Estimate for the current quarter has revised upward. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future. 

Pluristem Therapeutics currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Pluristem Therapeutics, Inc. Price and Consensus

Pluristem Therapeutics, Inc. Price and Consensus | Pluristem Therapeutics, Inc. Quote

ADVERTISEMENT

A better ranked stock in the Medical - Biomedical and Genetics industry is Exact Sciences Corporation EXAS which carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is PSTI going up? Or down? Predict to see what others think: Up or Down

Wall Street’s Next Amazon

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Pluristem Therapeutics, Inc. (PSTI) : Free Stock Analysis Report
 
Exact Sciences Corporation (EXAS) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research